Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

RECOVERY Collaborative Group, Peter W Horby, Natalie Staplin, Leon Peto, Jonathan R Emberson, Mark Campbell, Guilherme Pessoa-Amorim, Buddha Basnyat, Louise Thwaites, Rogier Van Doorn, Raph L Hamers, Jeremy Nel, John Amuasi, Richard Stewart, Dipansu Ghosh, Fergus Hamilton, Purav Desai, Nicholas Easom, Jaydip Majumdar, Paul Hine, David Chadwick, Graham Cooke, Sara Sharp, Hanif Esmail, J Kenneth Baillie, Maya H Buch, Saul N Faust, Thomas Jaki, Katie Jeffery, Edmund Juszczak, Marian Knight, Wei Shen Lim, Alan Montgomery, Aparna Mukherjee, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Marion Mafham, Richard Haynes, Martin J Landray
doi: https://doi.org/10.1101/2024.05.23.24307731

Article Information

doi 
https://doi.org/10.1101/2024.05.23.24307731
History 
  • May 24, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. RECOVERY Collaborative Group*,
  2. Peter W Horby1,#,
  3. Natalie Staplin2,
  4. Leon Peto2,
  5. Jonathan R Emberson2,
  6. Mark Campbell2,
  7. Guilherme Pessoa-Amorim2,
  8. Buddha Basnyat3,
  9. Louise Thwaites4,
  10. Rogier Van Doorn4,
  11. Raph L Hamers5,
  12. Jeremy Nel6,
  13. John Amuasi7,
  14. Richard Stewart8,
  15. Dipansu Ghosh9,
  16. Fergus Hamilton10,
  17. Purav Desai11,
  18. Nicholas Easom12,
  19. Jaydip Majumdar13,
  20. Paul Hine14,
  21. David Chadwick15,
  22. Graham Cooke16,
  23. Sara Sharp17,
  24. Hanif Esmail18,
  25. J Kenneth Baillie19,
  26. Maya H Buch20,
  27. Saul N Faust21,
  28. Thomas Jaki22,
  29. Katie Jeffery23,
  30. Edmund Juszczak24,
  31. Marian Knight25,
  32. Wei Shen Lim26,
  33. Alan Montgomery24,
  34. Aparna Mukherjee27,
  35. Andrew Mumford28,
  36. Kathryn Rowan29,
  37. Guy Thwaites4,
  38. Marion Mafham2,
  39. Richard Haynes2 and
  40. Martin J Landray2,#
  1. 1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
  2. 2Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
  3. 3OUCRU Nepal, Patan Academy of Health Sciences, Kathmandu, Nepal
  4. 4Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam, and Nuffield Department of Medicine, University of Oxford, United Kingdom
  5. 5Eijkman Oxford Clinical Research Unit, Jakarta, Indonesia
  6. 6Division of Infectious Diseases, Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa
  7. 7Kumasi Center for Collaborative Research in Tropic Medicine, Kumasi, Ghana
  8. 8Milton Keynes University Hospital, Milton Keynes, United Kingdom
  9. 9Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom
  10. 10University Hospital of Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
  11. 11Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, United Kingdom
  12. 12Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom
  13. 13Mid Cheshire Hospitals NHS Foundation Trust, United Kingdom
  14. 14Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
  15. 15South Tees Hospitals NHS Foundation Trust, United Kingdom
  16. 16Imperial College Healthcare NHS Trust, London, United Kingdom
  17. 17Medway NHS Foundation Trust, United Kingdom
  18. 18University College London Hospitals NHS Foundation Trust, London, United Kingdom
  19. 19Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom
  20. 20Centre for Musculoskeletal Research, University of Manchester, Manchester, United Kingdom
  21. 21NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, United Kingdom
  22. 22Department of Mathematics and Statistics, Lancaster University, Lancaster, United Kingdom
  23. 23Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
  24. 24School of Medicine, University of Nottingham, Nottingham, United Kingdom
  25. 25National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
  26. 26Respiratory Medicine Department, Nottingham University Hospitals NHS Foundation Trust, Nottingham, United Kingdom
  27. 27Indian Council of Medical Research, New Delhi, India
  28. 28School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
  29. 29Intensive Care National Audit and Research Centre, London, United Kingdom
  1. ↵#Correspondence to: Prof Peter W Horby and Prof Martin J Landray, RECOVERY Central Coordinating Office, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, United Kingdom. Email: recoverytrial{at}ndph.ox.ac.uk
Back to top
Posted May 24, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, Peter W Horby, Natalie Staplin, Leon Peto, Jonathan R Emberson, Mark Campbell, Guilherme Pessoa-Amorim, Buddha Basnyat, Louise Thwaites, Rogier Van Doorn, Raph L Hamers, Jeremy Nel, John Amuasi, Richard Stewart, Dipansu Ghosh, Fergus Hamilton, Purav Desai, Nicholas Easom, Jaydip Majumdar, Paul Hine, David Chadwick, Graham Cooke, Sara Sharp, Hanif Esmail, J Kenneth Baillie, Maya H Buch, Saul N Faust, Thomas Jaki, Katie Jeffery, Edmund Juszczak, Marian Knight, Wei Shen Lim, Alan Montgomery, Aparna Mukherjee, Andrew Mumford, Kathryn Rowan, Guy Thwaites, Marion Mafham, Richard Haynes, Martin J Landray
medRxiv 2024.05.23.24307731; doi: https://doi.org/10.1101/2024.05.23.24307731
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area